To quantify the DNA methylation status of SFRP1 promoter in clinical HCC samples, bisulfite-treated genomic DNA sequencing was employed to analyze the methylation level of CpG islands in three pairs of HCC specimens with the down-regulation of SFRP1 (Fig. 6A). The gene discussed is SFRP1; the disease is hepatocellular carcinoma.